title: [Neoadjuvant short-term radiotherapy followed by FOLFOX chemotherapy : No standard treatment for rectal cancer].
authors.affiliation: RadioOnkologie und Strahlentherapie, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. David.Krug@med.uni-heidelberg.de.
authors.forename: David
authors.initials: D
authors.lastname: Krug
authors.affiliation: RadioOnkologie und Strahlentherapie, UniversitätsKlinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
authors.forename: Matthias F
authors.initials: MF
authors.lastname: Häfner
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D059248:Chemoradiotherapy / Q000379:methods / Q000401:mortality*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D017408:Guidelines as Topic; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000517:prevention & control; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D011044:Poland / Q000453:epidemiology; D015995:Prevalence; D011832:Radiation Injuries / Q000401:mortality* / Q000517:prevention & control; D018714:Radiotherapy, Adjuvant / Q000379:methods / Q000401:mortality; D012004:Rectal Neoplasms / Q000401:mortality* / Q000628:therapy*; D018570:Risk Assessment; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil